Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1948 1
1950 1
1951 3
1953 5
1954 2
1955 3
1956 6
1957 3
1958 1
1959 2
1961 6
1962 5
1963 7
1964 11
1976 1
1978 1
1979 1
1986 1
1992 1
1993 4
1994 3
1995 113
1996 277
1997 341
1998 447
1999 445
2000 475
2001 485
2002 429
2003 482
2004 421
2005 502
2006 568
2007 527
2008 539
2009 538
2010 517
2011 538
2012 568
2013 562
2014 568
2015 557
2016 672
2017 629
2018 636
2019 417
2020 38
Text availability
Article attribute
Article type
Publication date

Search Results

11,373 results
Results by year
Filters applied: . Clear all
Page 1
The Cytokines of Asthma.
Lambrecht BN, Hammad H, Fahy JV. Lambrecht BN, et al. Immunity. 2019 Apr 16;50(4):975-991. doi: 10.1016/j.immuni.2019.03.018. Immunity. 2019. PMID: 30995510 Free article. Review.
Role of Biologics in Asthma.
McGregor MC, Krings JG, Nair P, Castro M. McGregor MC, et al. Am J Respir Crit Care Med. 2019 Feb 15;199(4):433-445. doi: 10.1164/rccm.201810-1944CI. Am J Respir Crit Care Med. 2019. PMID: 30525902 Free PMC article. Review.
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R; PRACTICAL study team. Hardy J, et al. Lancet. 2019 Sep 14;394(10202):919-928. doi: 10.1016/S0140-6736(19)31948-8. Epub 2019 Aug 23. Lancet. 2019. PMID: 31451207 Clinical Trial.
Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
Taniguchi M, Mitsui C, Hayashi H, Ono E, Kajiwara K, Mita H, Watai K, Kamide Y, Fukutomi Y, Sekiya K, Higashi N. Taniguchi M, et al. Allergol Int. 2019 Jul;68(3):289-295. doi: 10.1016/j.alit.2019.05.001. Epub 2019 Jun 21. Allergol Int. 2019. PMID: 31235242 Free article. Review.
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study.
Khurana S, Brusselle GG, Bel EH, FitzGerald JM, Masoli M, Korn S, Kato M, Albers FC, Bradford ES, Gilson MJ, Price RG, Humbert M. Khurana S, et al. Clin Ther. 2019 Oct;41(10):2041-2056.e5. doi: 10.1016/j.clinthera.2019.07.007. Epub 2019 Aug 22. Clin Ther. 2019. PMID: 31447130 Free article. Clinical Trial.
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.
Khatri S, Moore W, Gibson PG, Leigh R, Bourdin A, Maspero J, Barros M, Buhl R, Howarth P, Albers FC, Bradford ES, Gilson M, Price RG, Yancey SW, Ortega H. Khatri S, et al. J Allergy Clin Immunol. 2019 May;143(5):1742-1751.e7. doi: 10.1016/j.jaci.2018.09.033. Epub 2018 Oct 23. J Allergy Clin Immunol. 2019. PMID: 30359681 Free article. Clinical Trial.
Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma.
Bleecker ER, Wechsler ME, FitzGerald JM, Menzies-Gow A, Wu Y, Hirsch I, Goldman M, Newbold P, Zangrilli JG. Bleecker ER, et al. Eur Respir J. 2018 Oct 18;52(4):1800936. doi: 10.1183/13993003.00936-2018. Print 2018 Oct. Eur Respir J. 2018. PMID: 30139780 Free PMC article. Clinical Trial.
11,373 results
Jump to page
Feedback